Premium
Effects of phenobarbital and tobacco smoking on furosemide kinetics and dynamics in normal subjects
Author(s) -
Lambert C,
Larochelle P,
Souich P
Publication year - 1983
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1983.148
Subject(s) - phenobarbital , furosemide , chemistry , excretion , urine , diuretic , endocrinology , diuresis , medicine , creatinine , kinetics , endogeny , renal function , pharmacology , physics , quantum mechanics
This study was carried out to determine whether furosemide (F) kinetics and dynamics were influenced by phenobarbital and tobacco smoking. Our subjects were 10 normal men: five nonsmokers (NS) and five smokers (S). They received a single intravenous F injection of 40 mg. Regular serum and urine collections were made. In a second study, the NS group received 100 mg phenobarbital orally for 15 days and then a second dose of F. Cumulative 8‐hr urinary excretion of sodium was identical for NS, NS with phenobarbital, and S at 345 ± 30, 357 ± 29, and 353 ± 25 mmol. Diuresis was smaller by 800 ml (20%) in S than in NS. F increased endogenous creatinine clearance from 117 ± 13 to 196 ± 17 ml/min in NS and from 110 ± 12 to 222 ± 30 ml/min in NS with phenobarbital. In the S group, endogenous creatinine clearance showed a tendency to increase only slightly, from 136 ± 23 to 180 ± 34 ml/min. The increase in free water clearance caused by F was smaller in the S group than in the NS group (P < 0.05). Protein binding and distribution of F were not affected by phenobarbital or tobacco smoking. F clearance was slightly higher in S than in NS, which was primarily the result of a slight increase in extrarenal F clearance. In the NS group, F clearance remained constant after phenobarbital. It is concluded that tobacco smoking in normal subjects affects the diuretic response to F without modifying kinetics. Clinical Pharmacology and Therapeutics (1983) 34 , 170–175; doi: 10.1038/clpt.1983.148